Physician

Amrutha Mary George, M.D.

According to 2025 Medicare claims, Amrutha George, M.D. (NPI: 1013267194) practices endocrinology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is SWEDISHAMERICAN HOSPITAL (NPI: 1962451732; TIN: 362222696) and primary practice location at 61107-5639.

George's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 260 traditional Medicare patients, billed 807 HCPCS/CPT codes, and received $36,226 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,010 prescription claims across 534 beneficiaries totaling $1,898,595 in drug costs, led by Ozempic (Semaglutide). DME data shows 313 claims. Open Payments data shows 21 records totaling $566. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $9,221 to $1,898,595. For DME billing, reported payments moved sharply higher in recent years, from $1,945 to $88,561.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	72	90	$6,229
2018	211	300	$20,993
2019	244	991	$40,747
2020	260	1,403	$43,171
2021	286	2,989	$70,274
2022	285	6,195	$63,410
2023	235	12,004	$66,676
2024	260	807	$36,226

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	16	68	$9,221
2016	16	46	$1,390
2017	37	86	$8,900
2018	109	478	$96,887
2019	223	1,167	$561,874
2020	258	1,647	$774,859
2021	378	2,637	$1,192,879
2022	444	2,922	$1,511,612
2023	476	3,092	$1,718,729
2024	534	4,010	$1,898,595

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	13	$391
2019	34	111	$10,415
2020	74	251	$25,377
2021	95	405	$61,170
2022	79	343	$47,643
2023	92	378	$59,700
2024	106	313	$85,723

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	53	53	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	211	321	$68
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	44	81	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	166	233	$11
36415	Insertion of needle into vein for collection of blood sample	43	56	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	207	10,550	$340,235
Mounjaro	Tirzepatide	154	6,170	$229,118
Jardiance	Empagliflozin	186	11,575	$225,388
Trulicity	Dulaglutide	143	5,878	$198,048
Tresiba Flextouch U-200	Insulin Degludec	80	4,619	$118,284

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	46	195	$78,075
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	13	$3,240
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	14	14	$3,145
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	33	68	$1,227
A4259	Lancets, per box of 100	N	13	23	$37

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$566	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amrutha Mary George, M.D.?

Tedicare shows public-source Medicare data for Amrutha Mary George, M.D. (NPI 1013267194), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amrutha Mary George, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amrutha Mary George, M.D.?

Amrutha Mary George, M.D. is linked to SWEDISHAMERICAN HOSPITAL (billing NPI 1962451732) in the available physician profile data.

Does Amrutha Mary George, M.D. have Open Payments data?

Amrutha Mary George, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.